Skip to main content
Loading

Advancing AAV Gene Replacement & Editing: Precision Engineering for Durable and Targeted Therapeutic Outcomes

24 Jun 2025
Gene Therapy Manufacturing
  • Evaluating the benefits and limitations of different approaches for various genetic disorders
  • Optimizing AAV vector design to enhance delivery efficiency, specificity, and durability for improved therapeutic outcomes
  • Overcoming immunogenicity and safety concerns to asses immune responses, toxicity risks, and long term patient safety
Industry Expert
Uditha deAlwis, Vice President Analytical Development & Quality Control - Sarepta Therapeutics